Findings from Two Studies Evaluating up to 70,000 Patients Presented at the 2015 Annual ACOG Meeting
Good Start Genetics®, Inc., a commercial-stage molecular genetics information company, today presented data from two studies analyzing detection rates among patients at in vitro fertilization (IVF) clinics who underwent carrier screening for inherited diseases. The studies were presented at the 2015 Annual Clinical and Scientific Meeting of The American College of Obstetricians and Gynecologists (ACOG) being held in San Francisco, Calif.
The first study, titled “Carrier Screening with Next-Generation Sequencing Detects Common, Uncommon, and Novel Mutations,” evaluated 71,070 patients referred for carrier screening at IVF clinics across the U.S. Good Start Genetics utilized its next-generation DNA sequencing (NGS) platform to detect mutations causative of 14 genetic disorders recommended for carrier screening by ACOG, the American College of Medical Genetics and Genomics (ACMG), and the American Society for Reproductive Medicine (ASRM).
